Skip to main content
. 2021 Sep 23;59(5):88. doi: 10.3892/ijo.2021.5268

Figure 1.

Figure 1

CYTOR is overexpressed in NSCLC and high expression of CYTOR is associated with poor prognosis of patients with NSCLC. In total, 58 pairs of NSCLC and paracancerous tissues were harvested. (A) CYTOR expression analyzed by the starBase database (http://starbase.sysu.edu.cn/). (B) CYTOR expression in NSCLC tissues tested by RT-qPCR. (C) Survival curve analysis within a 60-month follow-up of 58 patients with patients divided into the CYTOR high- and low-expression group according to the median CYTOR expression level. (D) RT-qPCR was used to detect the expression of CYTOR according to radiosensitivity with patients stratified into sensitive (n=30) and resistant (n=28) groups. (E) CYTOR expression in normal and NSCLC cells. Values are expressed as the mean ± standard deviation. *P<0.05. NSCLC, non-small cell lung cancer; CYTOR, long noncoding RNA cytoskeleton regulator; RT-qPCR, reverse transcription-quantitative PCR; LUAD, lung adenocarcinoma; LUSC, lung squamous cell carcinoma.